Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series
Article in Journal of Neuroimmunology (August 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Journal of Neuroimmunology (August 2024)
Article in Expert Review of Clinical Pharmacology (May 2024)
Article in Journal of Inflammation Research (April 2024)